Yahoo Finance

BrightHeart Obtains Second FDA Clearance for Expansion of Platform Capabilities - Adding Tablet Support For Fetal Heart Ultrasound Evaluations

PARIS, May 06, 2025--(BUSINESS WIRE)--BrightHeart, a global leader in artificial intelligence (AI) solutions for obstetrics and pediatric cardiology, announced today the 510(k) clearance for updates ...
Business Wire

BrightHeart Unveils Breakthrough AI Results at the Society for Maternal-Fetal Medicine (SMFM) 2025 Pregnancy Meeting, Revolutionizing Prenatal Care

PARIS--(BUSINESS WIRE)--BrightHeart, a global leader in artificial intelligence (AI) solutions for obstetrics and pediatric cardiology, presented two groundbreaking studies during the oral plenary and ...
Morningstar

BrightHeart Raises €11M Series A to Scale Expert-Level AI Platform for Prenatal Ultrasound

BrightHeart, a global leader in artificial intelligence (AI) solutions for prenatal ultrasound, today announced the closing of an €11 million Series A financing round. The round was co-led by Odyssée ...
Business Wire

BrightHeart to Present Groundbreaking AI-Driven Research at the Society for Maternal-Fetal Medicine (SMFM) 2025 Pregnancy Meeting

PARIS--(BUSINESS WIRE)--BrightHeart, a leading AI innovator in obstetric and pediatric cardiology technology, announced today that the groundbreaking results of two key studies of the company’s ...
Finanznachrichten

BrightHeart Obtains Third FDA Clearance and PCCP Approval, Becoming First to Offer One Integrated Solution for Real-Time Fetal Heart Documentation and CHD Detection

BrightHeart, a global leader in artificial intelligence (AI) solutions for obstetrics and pediatric cardiology, announced today it has received 510(k) clearance from the U.S. Food and Drug ...
Morningstar

BrightHeart Unveils Breakthrough AI Results at the Society for Maternal-Fetal Medicine (SMFM) 2025 Pregnancy Meeting, Revolutionizing Prenatal Care

BrightHeart, a global leader in artificial intelligence (AI) solutions for obstetrics and pediatric cardiology, presented two groundbreaking studies during the oral plenary and concurrent sessions on ...